CCRM is a Canadian, not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based products and therapies. CCRM is supported by the Centres of Excellence for Commercialization and Research (CECR) program.
Centre for Commercialization of Regenerative Medicine
Regenerative Medicine News
- Sept 26/16
Stem cells from IFP patients used to create working 3D lungs to aid in research, personalized treatment.
- Sept 20/16
Removing cellular bookmarks smooths the path to stem cells.
- Sept 19/16
U of T allocates $27 million to 20 projects through Medicine by Design.
- Sept 16/16
Amgen to work with Italian scientists on new gene therapy.
- Sept 14/16
MRI guidance shows promise in delivering stem cell therapies.
- Aug 12/16
Key molecular signal that shapes regeneration in planarian stem cells discovered.
- Aug 5/16
Merck surges as Bristol's immunotherapy drug stumbles in lung cancer.
- Aug 5/16
Stem cell factor puts differentiation on speed dial.